Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Narcolepsy is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. These sudden sleep attacks may occur during any type of activity at any time of the day.
People with narcolepsy can be substantially helped, but not cured. Treatment is tailored to the individual, based on symptoms and therapeutic response. The time required to achieve optimal control of symptoms is highly variable and may take several months or longer. Medication adjustments are frequently necessary, and complete control of symptoms is seldom possible. While oral medications are the mainstay of formal narcolepsy treatment, lifestyle changes are also important.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Narcolepsy market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Narcolepsy market. Detailed analysis of key players, along with key growth strategies adopted by Narcolepsy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Ligand Pharmaceuticals, Inc (US)
Shire (Republic of Ireland)
BIOPROJET (Paris)
Shionogi Inc (US)
Novartis AG (Switzerland)
Jazz Pharmaceuticals plc (Republic of Ireland)
Graymark Healthcare, Inc (US)
Teva Pharmaceutical Industries Ltd (Israel)
Arena Pharmaceuticals, Inc (US)
Mylan NV (US)
By Type:
Polysomnogram
Multiple Sleep Latency Test
By End-User:
Hospitals
Retail Pharmacies
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Narcolepsy Market
-
1.3 Market Segment by Type
-
1.3.1 China Narcolepsy Market Size and Growth Rate of Polysomnogram from 2016 to 2027
-
1.3.2 China Narcolepsy Market Size and Growth Rate of Multiple Sleep Latency Test from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Narcolepsy Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 China Narcolepsy Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Narcolepsy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Narcolepsy by Major Types
-
3.4.1 Market Size and Growth Rate of Polysomnogram
-
3.4.2 Market Size and Growth Rate of Multiple Sleep Latency Test
4 Segmentation of Narcolepsy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Narcolepsy by Major End-Users
-
4.4.1 Market Size and Growth Rate of Narcolepsy in Hospitals
-
4.4.2 Market Size and Growth Rate of Narcolepsy in Retail Pharmacies
5 Market Analysis by Regions
-
5.1 China Narcolepsy Production Analysis by Regions
-
5.2 China Narcolepsy Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Narcolepsy Landscape Analysis
-
6.1 North China Narcolepsy Landscape Analysis by Major Types
-
6.2 North China Narcolepsy Landscape Analysis by Major End-Users
7 Central China Narcolepsy Landscape Analysis
-
7.1 Central China Narcolepsy Landscape Analysis by Major Types
-
7.2 Central China Narcolepsy Landscape Analysis by Major End-Users
8 South China Narcolepsy Landscape Analysis
-
8.1 South China Narcolepsy Landscape Analysis by Major Types
-
8.2 South China Narcolepsy Landscape Analysis by Major End-Users
9 East China Narcolepsy Landscape Analysis
-
9.1 East China Narcolepsy Landscape Analysis by Major Types
-
9.2 East China Narcolepsy Landscape Analysis by Major End-Users
10 Northeast China Narcolepsy Landscape Analysis
-
10.1 Northeast China Narcolepsy Landscape Analysis by Major Types
-
10.2 Northeast China Narcolepsy Landscape Analysis by Major End-Users
11 Southwest China Narcolepsy Landscape Analysis
-
11.1 Southwest China Narcolepsy Landscape Analysis by Major Types
-
11.2 Southwest China Narcolepsy Landscape Analysis by Major End-Users
12 Northwest China Narcolepsy Landscape Analysis
-
12.1 Northwest China Narcolepsy Landscape Analysis by Major Types
-
12.2 Northwest China Narcolepsy Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Ligand Pharmaceuticals, Inc (US)
-
13.1.1 Ligand Pharmaceuticals, Inc (US) Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Shire (Republic of Ireland)
-
13.2.1 Shire (Republic of Ireland) Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 BIOPROJET (Paris)
-
13.3.1 BIOPROJET (Paris) Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Shionogi Inc (US)
-
13.4.1 Shionogi Inc (US) Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Novartis AG (Switzerland)
-
13.5.1 Novartis AG (Switzerland) Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Jazz Pharmaceuticals plc (Republic of Ireland)
-
13.6.1 Jazz Pharmaceuticals plc (Republic of Ireland) Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Graymark Healthcare, Inc (US)
-
13.7.1 Graymark Healthcare, Inc (US) Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Teva Pharmaceutical Industries Ltd (Israel)
-
13.8.1 Teva Pharmaceutical Industries Ltd (Israel) Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Arena Pharmaceuticals, Inc (US)
-
13.9.1 Arena Pharmaceuticals, Inc (US) Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Mylan NV (US)
-
13.10.1 Mylan NV (US) Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Narcolepsy Market Size and Growth Rate of Polysomnogram from 2016 to 2027
-
Figure China Narcolepsy Market Size and Growth Rate of Multiple Sleep Latency Test from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Narcolepsy Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Narcolepsy Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Narcolepsy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Narcolepsy
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Narcolepsy by Different Types from 2016 to 2027
-
Table Consumption Share of Narcolepsy by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Polysomnogram
-
Figure Market Size and Growth Rate of Multiple Sleep Latency Test
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Narcolepsy by Different End-Users from 2016 to 2027
-
Table Consumption Share of Narcolepsy by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Retail Pharmacies
-
Table China Narcolepsy Production by Regions
-
Table China Narcolepsy Production Share by Regions
-
Figure China Narcolepsy Production Share by Regions in 2016
-
Figure China Narcolepsy Production Share by Regions in 2021
-
Figure China Narcolepsy Production Share by Regions in 2027
-
Table China Narcolepsy Consumption by Regions
-
Table China Narcolepsy Consumption Share by Regions
-
Figure China Narcolepsy Consumption Share by Regions in 2016
-
Figure China Narcolepsy Consumption Share by Regions in 2021
-
Figure China Narcolepsy Consumption Share by Regions in 2027
-
Table North China Narcolepsy Consumption by Types from 2016 to 2027
-
Table North China Narcolepsy Consumption Share by Types from 2016 to 2027
-
Figure North China Narcolepsy Consumption Share by Types in 2016
-
Figure North China Narcolepsy Consumption Share by Types in 2021
-
Figure North China Narcolepsy Consumption Share by Types in 2027
-
Table North China Narcolepsy Consumption by End-Users from 2016 to 2027
-
Table North China Narcolepsy Consumption Share by End-Users from 2016 to 2027
-
Figure North China Narcolepsy Consumption Share by End-Users in 2016
-
Figure North China Narcolepsy Consumption Share by End-Users in 2021
-
Figure North China Narcolepsy Consumption Share by End-Users in 2027
-
Table Central China Narcolepsy Consumption by Types from 2016 to 2027
-
Table Central China Narcolepsy Consumption Share by Types from 2016 to 2027
-
Figure Central China Narcolepsy Consumption Share by Types in 2016
-
Figure Central China Narcolepsy Consumption Share by Types in 2021
-
Figure Central China Narcolepsy Consumption Share by Types in 2027
-
Table Central China Narcolepsy Consumption by End-Users from 2016 to 2027
-
Table Central China Narcolepsy Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Narcolepsy Consumption Share by End-Users in 2016
-
Figure Central China Narcolepsy Consumption Share by End-Users in 2021
-
Figure Central China Narcolepsy Consumption Share by End-Users in 2027
-
Table South China Narcolepsy Consumption by Types from 2016 to 2027
-
Table South China Narcolepsy Consumption Share by Types from 2016 to 2027
-
Figure South China Narcolepsy Consumption Share by Types in 2016
-
Figure South China Narcolepsy Consumption Share by Types in 2021
-
Figure South China Narcolepsy Consumption Share by Types in 2027
-
Table South China Narcolepsy Consumption by End-Users from 2016 to 2027
-
Table South China Narcolepsy Consumption Share by End-Users from 2016 to 2027
-
Figure South China Narcolepsy Consumption Share by End-Users in 2016
-
Figure South China Narcolepsy Consumption Share by End-Users in 2021
-
Figure South China Narcolepsy Consumption Share by End-Users in 2027
-
Table East China Narcolepsy Consumption by Types from 2016 to 2027
-
Table East China Narcolepsy Consumption Share by Types from 2016 to 2027
-
Figure East China Narcolepsy Consumption Share by Types in 2016
-
Figure East China Narcolepsy Consumption Share by Types in 2021
-
Figure East China Narcolepsy Consumption Share by Types in 2027
-
Table East China Narcolepsy Consumption by End-Users from 2016 to 2027
-
Table East China Narcolepsy Consumption Share by End-Users from 2016 to 2027
-
Figure East China Narcolepsy Consumption Share by End-Users in 2016
-
Figure East China Narcolepsy Consumption Share by End-Users in 2021
-
Figure East China Narcolepsy Consumption Share by End-Users in 2027
-
Table Northeast China Narcolepsy Consumption by Types from 2016 to 2027
-
Table Northeast China Narcolepsy Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Narcolepsy Consumption Share by Types in 2016
-
Figure Northeast China Narcolepsy Consumption Share by Types in 2021
-
Figure Northeast China Narcolepsy Consumption Share by Types in 2027
-
Table Northeast China Narcolepsy Consumption by End-Users from 2016 to 2027
-
Table Northeast China Narcolepsy Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Narcolepsy Consumption Share by End-Users in 2016
-
Figure Northeast China Narcolepsy Consumption Share by End-Users in 2021
-
Figure Northeast China Narcolepsy Consumption Share by End-Users in 2027
-
Table Southwest China Narcolepsy Consumption by Types from 2016 to 2027
-
Table Southwest China Narcolepsy Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Narcolepsy Consumption Share by Types in 2016
-
Figure Southwest China Narcolepsy Consumption Share by Types in 2021
-
Figure Southwest China Narcolepsy Consumption Share by Types in 2027
-
Table Southwest China Narcolepsy Consumption by End-Users from 2016 to 2027
-
Table Southwest China Narcolepsy Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Narcolepsy Consumption Share by End-Users in 2016
-
Figure Southwest China Narcolepsy Consumption Share by End-Users in 2021
-
Figure Southwest China Narcolepsy Consumption Share by End-Users in 2027
-
Table Northwest China Narcolepsy Consumption by Types from 2016 to 2027
-
Table Northwest China Narcolepsy Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Narcolepsy Consumption Share by Types in 2016
-
Figure Northwest China Narcolepsy Consumption Share by Types in 2021
-
Figure Northwest China Narcolepsy Consumption Share by Types in 2027
-
Table Northwest China Narcolepsy Consumption by End-Users from 2016 to 2027
-
Table Northwest China Narcolepsy Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Narcolepsy Consumption Share by End-Users in 2016
-
Figure Northwest China Narcolepsy Consumption Share by End-Users in 2021
-
Figure Northwest China Narcolepsy Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Ligand Pharmaceuticals, Inc (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ligand Pharmaceuticals, Inc (US)
-
Figure Sales and Growth Rate Analysis of Ligand Pharmaceuticals, Inc (US)
-
Figure Revenue and Market Share Analysis of Ligand Pharmaceuticals, Inc (US)
-
Table Product and Service Introduction of Ligand Pharmaceuticals, Inc (US)
-
Table Company Profile and Development Status of Shire (Republic of Ireland)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire (Republic of Ireland)
-
Figure Sales and Growth Rate Analysis of Shire (Republic of Ireland)
-
Figure Revenue and Market Share Analysis of Shire (Republic of Ireland)
-
Table Product and Service Introduction of Shire (Republic of Ireland)
-
Table Company Profile and Development Status of BIOPROJET (Paris)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOPROJET (Paris)
-
Figure Sales and Growth Rate Analysis of BIOPROJET (Paris)
-
Figure Revenue and Market Share Analysis of BIOPROJET (Paris)
-
Table Product and Service Introduction of BIOPROJET (Paris)
-
Table Company Profile and Development Status of Shionogi Inc (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi Inc (US)
-
Figure Sales and Growth Rate Analysis of Shionogi Inc (US)
-
Figure Revenue and Market Share Analysis of Shionogi Inc (US)
-
Table Product and Service Introduction of Shionogi Inc (US)
-
Table Company Profile and Development Status of Novartis AG (Switzerland)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Switzerland)
-
Figure Sales and Growth Rate Analysis of Novartis AG (Switzerland)
-
Figure Revenue and Market Share Analysis of Novartis AG (Switzerland)
-
Table Product and Service Introduction of Novartis AG (Switzerland)
-
Table Company Profile and Development Status of Jazz Pharmaceuticals plc (Republic of Ireland)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jazz Pharmaceuticals plc (Republic of Ireland)
-
Figure Sales and Growth Rate Analysis of Jazz Pharmaceuticals plc (Republic of Ireland)
-
Figure Revenue and Market Share Analysis of Jazz Pharmaceuticals plc (Republic of Ireland)
-
Table Product and Service Introduction of Jazz Pharmaceuticals plc (Republic of Ireland)
-
Table Company Profile and Development Status of Graymark Healthcare, Inc (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Graymark Healthcare, Inc (US)
-
Figure Sales and Growth Rate Analysis of Graymark Healthcare, Inc (US)
-
Figure Revenue and Market Share Analysis of Graymark Healthcare, Inc (US)
-
Table Product and Service Introduction of Graymark Healthcare, Inc (US)
-
Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd (Israel)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd (Israel)
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd (Israel)
-
Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd (Israel)
-
Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd (Israel)
-
Table Company Profile and Development Status of Arena Pharmaceuticals, Inc (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arena Pharmaceuticals, Inc (US)
-
Figure Sales and Growth Rate Analysis of Arena Pharmaceuticals, Inc (US)
-
Figure Revenue and Market Share Analysis of Arena Pharmaceuticals, Inc (US)
-
Table Product and Service Introduction of Arena Pharmaceuticals, Inc (US)
-
Table Company Profile and Development Status of Mylan NV (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan NV (US)
-
Figure Sales and Growth Rate Analysis of Mylan NV (US)
-
Figure Revenue and Market Share Analysis of Mylan NV (US)
-
Table Product and Service Introduction of Mylan NV (US)
-
